Minyard

Leading Independent Proxy Advisory Firms ISS and Glass Lewis Both Recommend that SilverBow Resources Shareholders Vote “FOR” the Re-Election of SilverBow’s Three Director Nominees

Retrieved on: 
Thursday, May 9, 2024
Oil, Gas, Energy, Shirin David, Internet, ISS, Minyard, Annual general meeting, Institutional Shareholder Services, Eagle Ford, Dallas, Glass Lewis, Disclosure, Gold, Acquisition, Failure, Dissident, Glass, Telephone, ALL, Security (finance)

ISS and Glass Lewis recognize that SilverBow has the right Board and the right strategy to continue to deliver enhanced value for shareholders.

Key Points: 
  • ISS and Glass Lewis recognize that SilverBow has the right Board and the right strategy to continue to deliver enhanced value for shareholders.
  • The SilverBow Board remains committed to acting in the best interests of the Company and ALL SilverBow shareholders.
  • SilverBow strongly urges shareholders to follow ISS and Glass Lewis’s recommendations and vote “FOR” the re-election of SilverBow’s three highly qualified director nominees – Gabriel L. Ellisor, Kathleen McAllister and Charles W. Wampler – on the WHITE proxy card today.
  • If you have already voted using a gold proxy card, you may cancel that vote
    simply by voting again using the Company’s WHITE proxy card.

AllerVie Health Strengthens Leadership Team with VP Promotions and New Hire

Retrieved on: 
Thursday, March 28, 2024
Hospitals, Health Technology, Health, Practice Management, MD, Minyard, Patient, Multimedia, P&L, Allergy, Growth, Human resources, Acquisition, Management

Today, AllerVie Health , a national network of allergy clinics, announces several key vice president promotions and a new hire to its executive team.

Key Points: 
  • Today, AllerVie Health , a national network of allergy clinics, announces several key vice president promotions and a new hire to its executive team.
  • These strategic leadership moves solidify AllerVie Health's position as a frontrunner in allergy and immunology, with a continued focus on delivering exceptional care.
  • View the full release here: https://www.businesswire.com/news/home/20240327321188/en/
    "Our recent executive promotions and addition of a new VP represent our commitment to building a strong leadership team capable of driving innovation and delivering exceptional care to our patients," said Tae Kim, AllerVie Health CEO.
  • With a focus on collaboration, innovation, and continuous improvement, AllerVie Health is poised for continued growth and success in the healthcare landscape.

Ovintiv Appoints Katherine L. Minyard to Board of Directors

Retrieved on: 
Thursday, March 4, 2021
OVV, Minyard, INSEAD, Drug Enforcement Administration, Executive branch of the United States government, Government

DENVER, March 4, 2021 /PRNewswire/ - Ovintiv Inc. (NYSE: OVV) (TSX: OVV) today announced that Katherine L. Minyard has been appointed as an independent member of its board of directors, effective immediately.

Key Points: 
  • DENVER, March 4, 2021 /PRNewswire/ - Ovintiv Inc. (NYSE: OVV) (TSX: OVV) today announced that Katherine L. Minyard has been appointed as an independent member of its board of directors, effective immediately.
  • Minyard graduated from Texas A&M University, has an MBA from INSEAD in France, and holds the Chartered Financial Analyst designation.
  • Ovintiv's independent Board Chair Peter Dea stated, "We are pleased to welcome Kate to Ovintiv's Board and look forward to benefitting from her experience and perspectives.
  • With this appointment, we haveadded four new directors since early 2019 as part of our ongoing, multi-year refreshment process.